The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study by Santarsieri, Anna, MD, Mitchell, Emily, PhD, Pham, My H, MPhil, Sanghvi, Rashesh, MSc, Jablonski, Janina, MSc, Lee-Six, Henry, PhD, Sturgess, Katherine, PhD, Brice, Pauline, PhD, Menne, Tobias F, PhD, Osborne, Wendy, MD, Creasey, Thomas, PhD, Ardeshna, Kirit M, MD, Baxter, Joanna, PhD, Behan, Sarah, DipHE, Bhuller, Kaljit, MD, Booth, Stephen, MD, Chavda, Nikesh D, MD, Collins, Graham P, Prof, Culligan, Dominic J, MD, Cwynarski, Kate, PhD, Davies, Andrew, Prof, Downing, Abigail, MD, Dutton, David, MD, Furtado, Michelle, PhD, Gallop-Evans, Eve, PhD, Hodson, Andrew, MD, Hopkins, David, MD, Hsu, Hannah, MD, Iyengar, Sunil, PhD, Jones, Stephen G, MD, Karanth, Mamatha, MD, Linton, Kim M, PhD, Lomas, Oliver C, PhD, Martinez-Calle, Nicolas, PhD, Mathur, Abhinav, MD, McKay, Pamela, MD, Nagumantry, Sateesh K, MD, Phillips, Elizabeth H, MD, Phillips, Neil, MD, Rudge, John F, Prof, Shah, Nimish K, MD, Stafford, Gwyneth, BSc, Sternberg, Alex, MD, Trickey, Rachel, MD, Uttenthal, Benjamin J, PhD, Wetherall, Natasha, MD, Zhang, Xiao-Yin, MD, McMillan, Andrew K, PhD, Coleman, Nicholas, Prof, Stratton, Michael R, Prof, Laurenti, Elisa, PhD, Borchmann, Peter, Prof, Borchmann, Sven, PhD, Campbell, Peter J, PhD, Rahbari, Raheleh, PhD, Follows, George A, Prof

Get full text